The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Magnetic resonance spectroscopy in AD
Abstract
Ventilation-perfusion (V/Q) scan is an established technique used to monitor lung dysfunction in conditions such as pulmonary embolism.1 However, there are safety concerns regarding its use in several important populations e.g. pregnant women and children. Recent advances have transformed the use of standard clinical MRI equipment in functional lung imaging.2 We recently presented a clinically appropriate dynamic oxygen-enhanced MRI (dOE-MRI) protocol.3 In this work, we interpret dOE-MRI data with a novel physiological model of gas exchange4 that maps the regional distribution of lung ventilation and perfusion, simulating results from a standard V/Q scan. 3D dOE-MRI data were acquired using a 1.5 T Philips scanner as in:3 a 5 min baseline T1 acquisition, followed by a 15 min dynamic acquisition, during which the subject breathed 100% O2 for the middle 5 min. Total scan time is under 30 min throughout which the subject breathes normally. The partial pressure of oxygen in the alveolar compartment was derived as proposed in5 and maps of regional alveolar ventilation and perfusion were produced using a novel two-compartmental model of gas exchange based on.4 Figure 1 shows an example of whole-chest ventilation and perfusion maps from a healthy subject overlaid on a single volume of the acquired MRI (left column). The same maps are displayed as anterior/posterior and right/left anterior oblique projections (right column), equivalent to those achieved with V/Q scintigraphy.1 Estimation of alveolar ventilation and perfusion distribution from 3D dynamic OE-MRI is feasible and can be obtained under clinically acceptable conditions using standard radiological equipment without ionising radiation risks. This approach opens the possibility for regional assessment of lung physiology using a single short scanning session. References 1 Bajc, et al. Eur J Nucl Med Mol Imaging 2009;36(8):1356–70 2 Wild, et al. Insights Imaging 2012;3(4):345–53 3 Ulloa, et al. Proc Intl Soc Mag Reson Med. 2015;23:3973 4 Naish, et al. Proc Intl Soc Mag Reson Med. 2010;18:2516 5 Kershaw, et al. MRM 2010;64:1838–42
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline
Miller, B. L. (1991) · NMR in Biomedicine · doi:10.1002/nbm.1940040203 · Cited by 654
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
Simmons, M. L., Frondoza, C. G., & Coyle, J. T. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90101-s · Cited by 626
Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
Beal, M. F., Hyman, B. T., & Koroshetz, W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90117-5 · Cited by 574
Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W., & Sauter, R. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910110105 · Cited by 518
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: A 1H MRS study
Kantarci, K., Jack, C. R., Xu, Y. C., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2000) · Neurology · doi:10.1212/wnl.55.2.210 · Cited by 463
Bitsch, A., Bruhn, H., Vougioukas, V. I., Stringaris, A. K., Lassmann, H., Frahm, J., & Brück, W. (1999) · PubMed · Cited by 462
Reversible decreases in N‐acetylaspartate after acute brain injury
Stefano, N. D., Matthews, P. M., & Arnold, D. L. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340511 · Cited by 438
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P., & Clark, J. B. (1996) · PubMed · Cited by 422
N -Acetylaspartate in neuropsychiatric disorders
Tsai, G., & Coyle, J. T. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00014-m · Cited by 422
In vivo 1H MRS choline: Correlation with in vitro chemistry/histology
Miller, B. L., Changl, L., Booth, R., Ernst, T., Cornford, M., Nikas, D., McBride, D., & Jenden, D. J. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00182-8 · Cited by 367
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P. M. G., & Clark, J. B. (1996) · NeuroReport · doi:10.1097/00001756-199605310-00014 · Cited by 365
Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.
Miller, B. L., Moats, R. A., Shonk, T., Ernst, T., Woolley, S., & Ross, B. D. (1993) · Radiology · doi:10.1148/radiology.187.2.8475286 · Cited by 357
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
Ibáñez, V., Pietrini, P., Alexander, G. E., Furey, M. L., Teichberg, D., Rajapakse, J. C., Rapoport, S. I., Schapiro, M. B., & Horwitz, B. (1998) · Neurology · doi:10.1212/wnl.50.6.1585 · Cited by 322
Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J., & Ross, B. D. (1995) · Radiology · doi:10.1148/radiology.195.1.7892497 · Cited by 299
In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard
Christiansen, P., Henriksen, O., Stubgaard, M., Gideon, P., & Larsson, H. B. W. (1993) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(93)90418-d · Cited by 285
Bhakoo, K. K., & Pearce, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740254.x · Cited by 236
In vivo proton magnetic resonance spectroscopy of the normal aging human brain
Chang, L., Ernst, T., Poland, R. E., & Jenden, D. J. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00197-x · Cited by 220
Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease
Moats, R. A., Ernst, T., Shonk, T. K., & Ross, B. D. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320115 · Cited by 216
Ross, B. D. (1991) · NMR in Biomedicine · doi:10.1002/nbm.1940040205 · Cited by 215
Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains
Stokes, C. E., & Hawthorne, J. N. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05619.x · Cited by 206
Ernst, T., Chang, L., Melchor, R., & Mehringer, C. M. (1997) · Radiology · doi:10.1148/radiology.203.3.9169712 · Cited by 191
The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio
Brenner, R. E., Munro, P. M. G., Williams, S. C. R., Bell, J. D., Barker, G. J., Hawkins, C. P., Landon, D. N., & McDonald, W. I. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290605 · Cited by 185
Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study
Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J., & Muenz, L. R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90152-x · Cited by 183
Jessen, F., Block, W., Träber, F., Keller, E., Flacke, S., Papassotiropoulos, A., Lamerichs, R., Heun, R., & Schild, H. H. (2000) · Neurology · doi:10.1212/wnl.55.5.684 · Cited by 174
Meyrhoff, D. J., MacKay, S., Constans, J. ‐., Norman, D., Van Dyke, C., Fein, G., & Weiner, M. W. (1994) · Annals of Neurology · doi:10.1002/ana.410360110 · Cited by 160
John Savory, C. E. (1996) · Journal of Toxicology and Environmental Health · doi:10.1080/009841096161104 · Cited by 158
In vivo 31 P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia
Brown, G. G., Levine, S. R., Gorell, J. M., Pettegrew, J. W., Gdowski, J. W., Bueri, J. A., Helpern, J. A., & Welch, K. M. A. (1989) · Neurology · doi:10.1212/wnl.39.11.1423 · Cited by 157
Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease
Pettegrew, J. W., Klunk, W. E., Panchalingam, K., Kanfer, J. N., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80001-8 · Cited by 150
31P Nuclear Magnetic Resonance Study of the Brain in Alzheimerʼs Disease
Pettegrew, J. W., Moossy, J. J., Withers, G., McKeag, D., & Panchalingam, K. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198805000-00004 · Cited by 150
Pettegrew, J. W., Panchalingam, K., Moossy, J. J., Martinez, J., Rao, G., & Boller, F. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520340047010 · Cited by 150
Vion‐Dury, J., Meyerhoff, D. J., Cozzone, P. J., & Weiner, M. W. (1994) · Journal of Neurology · doi:10.1007/bf02033352 · Cited by 142
Hoang, T., Blüml, S., Dubowitz, D. J., Moats, R. A., Kopyov, O. V., Jacques, D., & Ross, B. D. (1998) · Neurology · doi:10.1212/wnl.50.4.1033 · Cited by 141
In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease
Adolf Pfefferbaum, A., Elfar Adalsteinsson, A., Spielman, D. M., Sullivan, E. V., & Lim, K. O. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.185 · Cited by 141
Reproducibility of 1H‐MRS in vivo
Brooks, W. M., Friedman, S. D., & Stidley, C. A. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199901)41:1<193::aid-mrm27>3.0.co;2-p · Cited by 139
Rose, S., de Zubicaray, G. I., Wang, D., Galloway, G. J., Chalk, J. B., Eagle, S., Semple, J. M., & Doddrell, D. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00168-4 · Cited by 135
Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
Parnetti, L., Tarducci, R., Presciutti, O., Lowenthal, D. T., Pippi, M., Palumbo, B., Gobbi, G., Pelliccioli, G. P., & Senin, U. (1997) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)01877-0 · Cited by 130
Parnetti, L., Lowenthal, D. T., Presciutti, O., Pelliccioli, G., Palumbo, R., Gobbi, G., Chiarini, P., Palumbo, B., Tarducci, R., & Senin, U. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb02428.x · Cited by 128
Vion‐Dury, J., Nicoli, F., Salvan, A.-M., Sylviane Confort-gouny, A., Dhiver, C., & Cozzone, P. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91184-7 · Cited by 116
In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Diseasea
de Leon, M. J., Convit, A. J., GEORGE, A. E., Golomb, J. B., Santi, S. D., Tarshish, C. Y., Rusinek, H., Bobinski, M., INCE, C., MILLER, D., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34395.x · Cited by 101
Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease
Young, L. T., Kish, S. J., Li, P. P., & Warsh, J. J. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90295-9 · Cited by 100
Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain
Klunk, W. E., Xu, C., Panchalingram, K., Mcclure, R. J., & Pettegrew, J. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00035-8 · Cited by 92
In vivo quantitation of metabolite concentrations in the brain by means of proton MRS
Henriksen, O. B. (1995) · NMR in Biomedicine · doi:10.1002/nbm.1940080402 · Cited by 85
Burri, R., Bigler, P., Straehl, P., Posse, S., Colombo, J. P., & HERSCHKOWITZ, N. N. (1990) · Neurochemical Research · doi:10.1007/bf00965747 · Cited by 80
Satlin, A., Bodick, N. C., Offen, W., & Renshaw, P. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.10.1459 · Cited by 76
Valenzuela, M., Sachdev, P. S., Wen, W., Shnier, R. C., Brodaty, H., & Gillies, D. (2000) · NeuroImage · doi:10.1006/nimg.2000.0629 · Cited by 76
Self-citationPrediction of cognitive decline in early Alzheimer's disease
Doraiswamy, P. M., Charles, H. C., & Krishnan, K. (1998) · The Lancet · doi:10.1016/s0140-6736(05)61449-3 · Cited by 73
Bottomley, P. A., Cousins, J. P., Pendrey, D. L., Wagle, W. A., Hardy, C. J., Eames, F. A., McCaffrey, R. J., & Thompson, D. A. (1992) · Radiology · doi:10.1148/radiology.183.3.1584923 · Cited by 68
Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia
Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02017-9 · Cited by 66
An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains
Mohanakrishnan, P., Fowler, A. H., Vonsattel, J. P., Husain, M. M., Jolles, P. R., Liem, P. H., & Komoroski, R. A. (1995) · Experimental Brain Research · doi:10.1007/bf00230654 · Cited by 62
Metabolic alterations in postmortem Alzheimer’s disease brain are exaggerated by Apo-E4
Klunk, W. E., Panchalingam, K., McClure, R. J., Stanley, J. A., & Pettegrew, J. W. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00105-5 · Cited by 56
Pharmacokinetics, Pharmacodynamics, and Safety of Metrifonate in Patients with Alzheimer's Disease
Pettigrew, L. C., Bieber, F., Lettieri, J., Wermeling, D. P., Schmitt, F. A., Tikhtman, A. J., Ashford, J. W., Smith, C. D., Wekstein, D. R., Markesbery, W. R., et al. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04421.x · Cited by 53
Murphy, D., Bottomley, P. A., Salerno, J. A., DeCarli, C., Mentis, M. J., Grady, C. L., Teichberg, D., Giacometti, K. R., Rosenberg, J. M., & Hardy, C. J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170019003 · Cited by 51
Oppenheimer, S. M., Bryan, R. N., Conturo, T. E., Soher, B. J., Preziosi, T. J., & Barker, P. B. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330109 · Cited by 46
Quantitative In Vivo 31P Magnetic Resonance Spectroscopy of Alzheimer Disease
Gonz??lez, R. G., Guimarães, A. R., Moore, G. J., Crawley, A. P., Cupples, L. A., & Growdon, J. H. (1996) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199601010-00008 · Cited by 33
Brain proton spectroscopy in dementia: an aid to clinical diagnosis
Rai, G. S., McConnell, J., Waldman, A. D., Grant, D. S., & Chaudry, M. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03759-3 · Cited by 27
Longo, R., BAMPO, A., VIDIMARI, R., Magnaldi, S., & Giorgini, A. (1995) · Investigative Radiology · doi:10.1097/00004424-199504000-00001 · Cited by 22
Epidemiology and neurobiology of the multiple determinants of Alzheimer's disease
Friedland, R. P. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90121-x · Cited by 17
Applications of Magnetic Resonance Spectroscopy to Psychiatry
Sanacora, G., Rothman, D. L., & Krystal, J. H. (1999) · The Neuroscientist · doi:10.1177/107385849900500316 · Cited by 7
Cited by
Brain reserve and dementia: a systematic review
VALENZUELA, M. J., & SACHDEV, P. (2006) · Psychological Medicine · doi:10.1017/s0033291705006264 · Cited by 932
Self-citationHan, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626
1 H MR spectroscopy in common dementias
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Tang-Wai, D. F., O’Brien, P. C., Weigand, S. D., Edland, S. D., Smith, G. E., Ivnik, R. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000141849.21256.ac · Cited by 262
Steen, R. G., Hamer, R. M., & Lieberman, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300850 · Cited by 254
“…al, 2004), epilepsy (Bernasconi et al, 2003; Vermathen et al, 2003), vascular dementia (Schuff et al, 2003), Alzheimer disease (Dixon et al, 2002; Valenzuela and Sachdev, 2001), Huntington disease (Sanchez-Pernaute et al, 1999), spinocerebellar ataxia (Guerrini et al, 2004), perinatal asphyxia…”
BackgroundBody mass index and magnetic resonance markers of brain integrity in adults
Gazdzinski, S., Kornak, J., Weiner, M. W., & Meyerhoff, D. J. (2008) · Annals of Neurology · doi:10.1002/ana.21377 · Cited by 191
“Spectroscopic studies in AD consistently demonstrated lower NAA(40,41) and greater m-Ino(42) levels in GM of medial temporal lobe and parietal lobes, but reports about Cho were inconclusive.(43) Nevertheless, given the epidemiological associations between midlife adiposity and increased chances of AD, our results sugg…”
Result
Metadata
- Authors
- Valenzuela, M. J., & Sachdev, P.
- Venue
- Neurology
- Published
- 2001-03-13
- Volume
- 56
- Issue
- 5
- Pages
- 592-598
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1984229043
- Cited by
- 255
- References
- 59
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.